For in vitro diagnostic use. Others Elecsys EBV EBNA IgG IVD Elecsys® EBV EBNA IgG CPS_000255 08355371190 EBV EBNA IgG Elecsys cobas e 100 Elecsys EBV EBNA IgG 07613336154137 Reagents, kits 100 tests cobas e 411/601/602 true 08355380190 EBV EBNA IgG Elecsys E2G 300 Elecsys EBV EBNA IgG 07613336154144 Reagents, kits 300 tests cobas e 402/801 true 08355371500 Elecsys EBV EBNA IgG en 3 FF0000000615FD0E FF00000003F64F0E 08355371190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of IgG antibodies to Epstein‑Barr virus (EBV) nuclear antigen‑1 (EBNA‑1) in human serum and plasma. The test is intended for use as an aid in the diagnosis of an infectious mononucleosis and the determination of the EBV infection stage.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08355380500 Elecsys EBV EBNA IgG en 3 FF0000000607610E FF00000004D1130E 08355380190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of IgG antibodies to Epstein‑Barr virus (EBV) nuclear antigen‑1 (EBNA‑1) in human serum and plasma. The test is intended for use as an aid in the diagnosis of an infectious mononucleosis and the determination of the EBV infection stage.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08355380500 Elecsys EBV EBNA IgG en 1 FF00000003FBC80E FF00000003C6F90E 08355380190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of IgG antibodies to Epstein‑Barr virus (EBV) nuclear antigen‑1 (EBNA‑1) in human serum and plasma. The test is intended for use as an aid in the diagnosis of an infectious mononucleosis and the determination of the EBV infection stage.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en